The if's, and's, or but's regarding bisphosphonates for prostate cancer.
Wilt
Timothy J
TJ
Ensrud
Kristine E
KE
D000230:Adenocarcinoma / Q000150:complications* / Q000556:secondary; D000726:Androgen Antagonists / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001847:Bone Diseases / Q000209:etiology* / Q000628:therapy*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000726:Androgen Antagonists; D050071:Bone Density Conservation Agents; D004164:Diphosphonates